16
Mar 2026
In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic lateral sclerosis (ALS), with exploratory findings suggesting target engagement and potential clinical benefits.
16
Mar 2026
A team of University of Mississippi researchers is developing a way to use 3D printed medicated patches to help close persistent sores and ulcers.
16
Mar 2026
New research from the University of Mississippi suggests that telling stories – from ancient campfire tales to modern-day digital communication – may be tied to how human memory evolved.
16
Mar 2026
A new study published in The Lancet Global Health reveals a previously underappreciated tension at the heart of international climate negotiations: policies designed to protect developing countries from bearing an unfair share of the cost of cutting carbon emissions could inadvertently deprive those same countries of millions of life-saving air quality improvements.
16
Mar 2026
A Japanese registry has identified a blind spot in the routine care of patients with chronic kidney disease (CKD). Serum bicarbonate levels are rarely measured, leaving metabolic acidosis largely undetected and hence, undertreated.
16
Mar 2026
Loss of communication can be among the most devastating symptoms for patients with paralysis. A new study by investigators from Mass General Brigham Neuroscience Institute and Brown University describes an investigational implantable brain computer interface (iBCI) typing neuroprosthesis that can restore communication with speed and accuracy.
16
Mar 2026
A modeling study in Nutrients projected that raising average milk consumption in Japan to recommended levels could reduce stroke incidence, stroke mortality, and healthcare spending over 10 years. The analysis suggests that modest dietary changes, particularly increased milk intake, may produce measurable population-level health and economic benefits.
16
Mar 2026
A new analysis in Oregon reveals a heightened incidence of severe burns requiring hospital-level care as illicit drug use has shifted nationwide from injection to smoking.
16
Mar 2026
An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma, or roughly a drop of blood.
16
Mar 2026
Deciding if and when to pursue deep brain stimulation (DBS) can be overwhelming for people with Parkinson's disease. While DBS is one of the most effective interventions for movement symptoms, it's also among the most complex.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
